Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05180721 · ClinicalTrials.gov registry record · NA
A Multi-level Intervention to Increase Access and Use of the Patient Portal
A NA study of Diabetes Mellitus, Type 2 and Patient Education, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 2
- Study locations
NCT05180721 is a NA study of Diabetes Mellitus, Type 2 and Patient Education that has completed, run by Yale University. The registered enrollment target is 26 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05180721, a NA study of Diabetes Mellitus, Type 2 and Patient Education, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to develop and evaluate a multi-level intervention aimed at increasing access and use of patient portals for diabetes management (MAP) in community health centers (CHCs).
Conditions Studied
Interventions
- BEHAVIORAL Use of patient portal for diabetes management
Study Locations (2)
Connecticut
- Fair Haven Community Health Center - New Haven
- Norwalk Community Health Center - Norwalk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2022-10-03 |
| Est. Completion | 2024-07-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05180721
The ClinicalTrials.gov registry entry for NCT05180721 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Use of patient portal for diabetes management is the first listed.
NCT05180721 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05180721 about?
NCT05180721 is a clinical study titled "A Multi-level Intervention to Increase Access and Use of the Patient Portal". The purpose of the study is to develop and evaluate a multi-level intervention aimed at increasing access and use of patient portals for diabetes management (MAP) in community health centers (CHCs).
What is the current status of trial NCT05180721?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2022-10-03. Estimated completion is 2024-07-02.
What conditions does trial NCT05180721 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Patient Education.
What interventions are being tested in trial NCT05180721?
The interventions under investigation include: Use of patient portal for diabetes management (BEHAVIORAL).
Who is sponsoring clinical trial NCT05180721?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05180721 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.